154 related articles for article (PubMed ID: 31769620)
1. CCN1 stimulated the osteoblasts via PTEN/AKT/GSK3β/cyclinD1 signal pathway in Myeloma Bone Disease.
Yan S; Liu H; Liu Z; Peng F; Jiang F; Li L; Fu R
Cancer Med; 2020 Jan; 9(2):737-744. PubMed ID: 31769620
[TBL] [Abstract][Full Text] [Related]
2. CYR61/CCN1 stimulates proliferation and differentiation of osteoblasts in vitro and contributes to bone remodeling in vivo in myeloma bone disease.
Liu H; Peng F; Liu Z; Jiang F; Li L; Gao S; Wang G; Song J; Ruan E; Shao Z; Fu R
Int J Oncol; 2017 Feb; 50(2):631-639. PubMed ID: 28035364
[TBL] [Abstract][Full Text] [Related]
3. Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer.
Gao C; Yuan X; Jiang Z; Gan D; Ding L; Sun Y; Zhou J; Xu L; Liu Y; Wang G
Breast Cancer Res Treat; 2019 Jul; 176(2):291-301. PubMed ID: 31006103
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone induces osteoblast apoptosis through ROS-PI3K/AKT/GSK3β signaling pathway.
Deng S; Dai G; Chen S; Nie Z; Zhou J; Fang H; Peng H
Biomed Pharmacother; 2019 Feb; 110():602-608. PubMed ID: 30537677
[TBL] [Abstract][Full Text] [Related]
5. Diminished membrane recruitment of Akt is instrumental in alcohol-associated osteopenia via the PTEN/Akt/GSK-3β/β-catenin axis.
Chen YX; Zhu DY; Gao J; Xu ZL; Tao SC; Yin WJ; Zhang YL; Gao YS; Zhang CQ
FEBS J; 2019 Mar; 286(6):1101-1119. PubMed ID: 30656849
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease.
Eda H; Santo L; Wein MN; Hu DZ; Cirstea DD; Nemani N; Tai YT; Raines SE; Kuhstoss SA; Munshi NC; Kronenberg HM; Raje NS
J Bone Miner Res; 2016 Jun; 31(6):1225-34. PubMed ID: 26763740
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-1297 suppressed the Akt/GSK3
Wang Q; Luo J; Sun R; Liu J
J Int Med Res; 2021 Apr; 49(4):300060520982104. PubMed ID: 33843359
[TBL] [Abstract][Full Text] [Related]
9. GLS1 promotes proliferation in hepatocellular carcinoma cells via AKT/GSK3β/CyclinD1 pathway.
Xi J; Sun Y; Zhang M; Fa Z; Wan Y; Min Z; Xu H; Xu C; Tang J
Exp Cell Res; 2019 Aug; 381(1):1-9. PubMed ID: 31054856
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell contact promotes CCN1 splicing and transcription in myeloma cells.
Dotterweich J; Ebert R; Kraus S; Tower RJ; Jakob F; Schütze N
Cell Commun Signal; 2014 Jun; 12():36. PubMed ID: 24965524
[TBL] [Abstract][Full Text] [Related]
11. PTEN silencing enhances neuronal proliferation and differentiation by activating PI3K/Akt/GSK3β pathway in vitro.
Song Z; Han X; Shen L; Zou H; Zhang B; Liu J; Gong A
Exp Cell Res; 2018 Feb; 363(2):179-187. PubMed ID: 29305963
[TBL] [Abstract][Full Text] [Related]
12. Constitutively expressed COX-2 in osteoblasts positively regulates Akt signal transduction via suppression of PTEN activity.
Li CJ; Chang JK; Wang GJ; Ho ML
Bone; 2011 Feb; 48(2):286-97. PubMed ID: 20854947
[TBL] [Abstract][Full Text] [Related]
13. CCN1 promotes tumorigenicity through Rac1/Akt/NF-κB signaling pathway in pancreatic cancer.
Wang X; Deng Y; Mao Z; Ma X; Fan X; Cui L; Qu J; Xie D; Zhang J
Tumour Biol; 2012 Oct; 33(5):1745-58. PubMed ID: 22752926
[TBL] [Abstract][Full Text] [Related]
14. CCN1/Cyr61-PI3K/AKT signaling promotes retinal neovascularization in oxygen-induced retinopathy.
Di Y; Zhang Y; Nie Q; Chen X
Int J Mol Med; 2015 Dec; 36(6):1507-18. PubMed ID: 26459773
[TBL] [Abstract][Full Text] [Related]
15. CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease.
Johnson SK; Stewart JP; Bam R; Qu P; Barlogie B; van Rhee F; Shaughnessy JD; Epstein J; Yaccoby S
Blood; 2014 Sep; 124(13):2051-60. PubMed ID: 25061178
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑4712‑5p promotes proliferation of the vulvar squamous cell carcinoma cell line A431 by targeting PTEN through the AKT/cyclin D1 signaling pathways.
Yang S; Zhao Y; Wang L; Liu C; Lu Y; Fang Z; Shi H; Zhang W; Wu X
Oncol Rep; 2019 Nov; 42(5):1689-1698. PubMed ID: 31545465
[TBL] [Abstract][Full Text] [Related]
17. Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.
Shi Y; Gera J; Hu L; Hsu JH; Bookstein R; Li W; Lichtenstein A
Cancer Res; 2002 Sep; 62(17):5027-34. PubMed ID: 12208757
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-19a functions as an oncogene by regulating PTEN/AKT/pAKT pathway in myeloma.
Zhang X; Chen Y; Zhao P; Zang L; Zhang Z; Wang X
Leuk Lymphoma; 2017 Apr; 58(4):932-940. PubMed ID: 27830963
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
20. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
Hu W; Xiao L; Cao C; Hua S; Wu D
Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
